Mammalian Transient Protein Expression Market Report (2023 to 2031) – Promega Corporation, Agilent Technologies, Inc., Takara Bio, and Bio-Rad Laboratories

Newark, New Castle, USA, June 15, 2023 (GLOBE NEWSWIRE) — The market analysis of the global mammalian transient protein expression market was conducted by Growth Plus Reports in 2022 and valued at US$ 642.12 million. The market is expected to hit a revenue CAGR of 7.9% to reach US$ 1,280.94 million by 2031.

Analysis of the global market for mammalian transient protein expression indicates that during the forecast period, revenue share is likely to increase significantly. 

The mammalian transient protein expression market plays a significant role in the production of recombinant proteins for various applications, including research, drug discovery, and therapeutic development. Mammalian cell-based expression systems offer the advantage of producing proteins with proper folding and post-translational modifications, making them suitable for applications where protein function and biological activity are critical. With ongoing advancements in biotechnology and increasing demand for biologics, the market for mammalian transient protein expression is expected to continue its growth trajectory in the coming years.

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/mammalian-transient-protein-expression-market/8937

                  Mammalian Transient Protein Expression Market Scope

The mammalian transient protein expression market is experiencing significant growth and dynamics driven by factors such as the increasing demand for biologics and personalized medicine, advancements in cell culture and transfection technologies, and the expanding field of proteomics and protein engineering. The market is fueled by the rising prevalence of chronic diseases and the need for novel therapies, leading to a growing demand for recombinant protein production. 

Additionally, collaborations between academic institutions, research organizations, and biotechnology companies are contributing to advancements in the field, enabling more efficient and scalable transient protein expression systems. As a result, the market is expected to continue expanding in the foreseeable future, with a focus on improving protein yield and quality and developing new applications for transient protein expression in various sectors, including research, drug discovery, and therapeutics.

Recent Development in the Mammalian Transient Protein Expression Market: 

• In March 2022, the XtenCHOTM Transient Expression System was introduced by ProteoGenix. Thanks to its increased plasmid stability and optimized metabolism, the innovative patented mammalian cell-based expression host generates up to 10 times better yields with less manual work than competing techniques.

Competitive Landscape

A list of the prominent players operating in the global market for mammalian transient protein expression includes: 

• Merck KGaA
• Promega Corporation
• Lonza Group AG
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Corporation 

Market Segmentation: 

Based on products, the global mammalian transient protein expression market is segmented into reagents & consumables, instruments, expression vectors, and cell lines. 

Based on applications, the global mammalian transient protein expression market is segmented into functional cell-based assays, bio-production, therapeutic protein production, and antibody production.

Based on end-user, the global mammalian transient protein expression market is segmented into biopharmaceutical companies, contract research organizations, and academic research & institutes.

The biopharmaceutical companies segment accounts for the largest revenue share in the global mammalian transient protein expression market.

Based on the region, North America, with the largest revenue share, dominates the global mammalian transient protein expression market. 

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/mammalian-transient-protein-expression-market/8937

Report Coverage 

Global market research on the mammalian transient protein expression market was done in-depth by Growth Plus Reports. We looked at the core market traits, noteworthy investment prospects, regional growth trends, ten-year revenue projections, rival market participants, and mergers and acquisitions.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3.  Opportunities
5. GLOBAL MAMMALIAN TRANSIENT PROTEIN EXPRESSION MARKET – ANALYSIS & FORECAST, BY PRODUCT
   1. Reagents & Consumables
   2. Instruments
   3. Expression Vector
   4. Cell Lines
6. GLOBAL MAMMALIAN TRANSIENT PROTEIN EXPRESSION MARKET – ANALYSIS & FORECAST, BY APPLICATION
   1. Functional Cell-Based Assays
   2. Bio-Production
      1. Therapeutic Protein Production
      2. Antibody Production

MAMMALIAN TRANSIENT PROTEIN EXPRESSION MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8937

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Glucose Elevating Agents Market by Products (Glucagon, Diazoxide), Indication (Hypoglycemia, Insulinoma), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), – Global Outlook & Forecast 2023-2031

Ergocalciferol Market by Application (Hypoparathyroidism, Rickets), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Leptin Based Therapeutics Market by Application (Obesity, Diabetes), Type (Recombinant Leptin, Leptin Receptor Agonists), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

ABCA4 Retinopathy Therapeutics Market by Drug Type (Anti-VEGF Drugs, LBS-008), Age Group (Children, Adults), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) – Global Outlook & Forecast 2023-2031

Tocolytic Agents Market by Drug Class (Magnesium Sulfate, Betamimetics), Route of Administration (Oral, Parenteral) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.